ENTA - Enanta Pharma GAAP EPS of -$1.53 misses by $0.16 revenue of $19.48M misses by $1.25M August, 08 2022 04:10 PM Enanta Pharmaceuticals Inc. Enanta Pharma press release ( NASDAQ: ENTA ): Q3 GAAP EPS of -$1.53 misses by $0.16 . Revenue of $19.48M (-9.8% Y/Y) misses by $1.25M . For further details see: Enanta Pharma GAAP EPS of -$1.53 misses by $0.16, revenue of $19.48M misses by $1.25M